| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
684 |
| issn |
1948-5875 |
| issueIdentifier |
5 |
| pageRange |
683-684 |
| publicationName |
ACS Medicinal Chemistry Letters |
| startingPage |
683 |
| bibliographicCitation |
Sabnis RW. Novel Pyrazolo[3,4-b]pyrazines as SHP2 Inhibitors for Treating Cancer. ACS Med. Chem. Lett. 2021 Apr 13;12(5):683–4. doi: 10.1021/acsmedchemlett.1c00173. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7289-0581 |
| date |
2021-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC8155244
https://pubmed.ncbi.nlm.nih.gov/34055208
https://doi.org/10.1021/acsmedchemlett.1c00173 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37641
https://portal.issn.org/resource/ISSN/1948-5875 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Novel Pyrazolo[3,4-b]pyrazines as SHP2 Inhibitors for Treating Cancer |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fa2ab9fe838f009771a4a21a0ae3d1aa
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_993c88b13f18d552189e047b2e4f07c2 |